Today: 6 February 2026
Subscribe
Browse Category

NASDAQ:TOVX News 24 October 2025

Theriva Biologics (TOVX) Stock Soars 92% on Oncolytic Virus Trial News – Can the Rally Last?

Theriva Biologics (TOVX) Stock Surges on Cancer Trial Breakthrough – What’s Next?

Theriva’s Stock Swing: In mid-October, Theriva’s Nasdaq-traded shares spiked on news of clinical success. On Oct. 15 the stock jumped from roughly $0.44 to $0.84 intradayts2.tech, an increase of about 92%. This surge coincided with reports that VCN-01 had met the primary endpoints in the VIRAGE Phase 2b trial (see below). The very next trading day, Theriva disclosed a $4.0…
24 October 2025
·····

Stock Market Today

  • Strathcona Resources Shares Fall Below 50-Day Moving Average Amid Mixed Analyst Ratings
    February 6, 2026, 12:10 PM EST. Shares of Strathcona Resources Ltd. (TSE:SCR) dropped below its 50-day moving average of C$32.28, trading as low as C$26.53. The stock last traded at C$27.15 on Thursday, with 287,608 shares changing hands. Analyst opinions vary: TD Securities and National Bank of Canada issue bullish outlooks with target prices of C$36.00 and strong-buy ratings, while Royal Bank of Canada and Jefferies suggest more cautious views. The company recently paid a quarterly dividend of C$0.30, yielding 4.4%. Strathcona Resources, a Canadian oil and gas producer focused on thermal oil and enhanced recovery, holds a market cap of C$5.87 billion. Its price-to-earnings ratio stands at 5.35, with a high beta of 2.61, indicating increased volatility.
Go toTop